Cargando…
PReS-FINAL-2274: Antiadalimumab antibodies in pediatric rheumatology patients. A pilot experience
Autores principales: | Murias Loza, S, Alcobendas Rueda, RM, Remesal Camba, A, Pascual Salcedo, D, Peralta, J, Merino Muñoz, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044380/ http://dx.doi.org/10.1186/1546-0096-11-S2-P264 |
Ejemplares similares
-
PReS-FINAL-2366: Paediatric rheumatology in South Africa
por: Scott, C
Publicado: (2013) -
PReS-FINAL-2257: Pediatric rheumatology in a rare disease working group: examples of diagnoses
por: Solyom, A, et al.
Publicado: (2013) -
PReS-FINAL-2365: Southern hemisphere educational partnership for pediatric arthritis and rheumatological diseases (Sheppard): pediatric rheumatology without borders
por: Russo, RA, et al.
Publicado: (2013) -
PReS-FINAL-2273: Clinical and laboratory characteristics of patients with fever of unknown origin in two Colombian pediatric rheumatology centers from 2010 to 2013
por: Eraso, RM, et al.
Publicado: (2013) -
PReS13-SPK-1127: Pediatric rheumatology in India
por: Khubchandani, RP
Publicado: (2013)